New Antibody
NanoAct ™
NanoAct ™ is the labeling particles for in vitro diagnostics (IVD) newly developed by Asahi Kasei.
Utilizing our cellulose technology matured and advanced for more than 80 years, we developed the NanoAct ™ colored cellulose nano beads. Using NanoAct ™ as the labeling particles for IVD, not only having a multicolor product line but also increased sensitivity and faster detection time are expected.
-
Model studies
The results of hCG and Troponin I (TnI) assays are provided as reference examples.
-
Results of a
clinical test
of influenza test kitsThe performance of commercially available kits using
NanoAct ™ is presented.
Microline ™
Asahi Kasei offers various types of nonwoven fabrics, and in that context, sells appropriate pads for IVD under the Microline ™ brand. They have excellent characteristics, such as uniformity, and can be used for various applications. In addition, various sizes are available to meet customers’ requests.
Learn More
Anti-L7/L12 protein Antibody
We have various antibodies that specifically recognize L7/L12 proteins in ribosomes present in bacteria. These antibodies have the potential to improve the sensitivity of your test kits. We can also develop antibodies to meet your requirements.
Learn More
TOPICS
Learn More- 2022.09.06NEWS
-
2021.09.03Exhibition
2021/9/26-9/30 2021 AACC ANNUAL SCIENTIFIC MEETING & CLINICAL LAB EXPO
-
2020.12.08NEWS
CareStart™ COVID-19 Antigen test kit using NanoAct™ launched in the U.S.